Clinical Trial: Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit(R)-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07918001) titled 'Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit(R)-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris' on Oct. 08.

Brief Summary: The CLEAN ACNE Study is a prospective, observational, Phase IV, open-label, multicenter, single-arm study at 3-5 sites in Vietnam. It will describe the safety, tolerability, and clinical effectiveness of adapalene 0.1%/clindamycin 1% fixed-dose combination gel (Klenzit(R)-C) as used in routine clinical practice. Participants are Vietnamese patients aged 12 years and older with mild to moderate acne vulgaris.

Patients whose treating physician has ...